Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioLineRx Ltd. Board/Management Information 2023

Dec 12, 2023

6692_rns_2023-12-12_e1c9c4d6-6cda-4a15-831a-60173f930ab0.htm

Board/Management Information

Open in viewer

Opens in your device viewer

Appointment of Gal Cohen to its Board of Director false

������� �� ��� ��"� 2 380
BIOLINE RX LTD
Corporation no: 513398750 8688
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 12/12/2023
www.isa.gov.il www.tase.co.il Reference: 2023-02-135168 Time of broadcast: 14:14 14:14

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onAppointment of Gal Cohen to its Board of Director

Form_6-k_GC_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 05/12/2023
Address: HaMa'ayan 2 , Modi'in 7177871   , Israel Tel: 08-6429100 , Fax: 08-6429101
E-mail address: [email protected]   Company site: www.biolinerx.com
Previous names of reporting entity:
Name of the Signatory: Serlin Philip Adam Position of Signatory in the reporting corporation: Chief Executive Officer Name of Employer Company:
Address: HaMa'ayan 2 , Modi'in 7177871 Telephone: 08-6429100 Facsimile: 08-6429101 E-mail: [email protected] 1
Israel